"Ill-informed and erroneous': Govt refutes reports claiming admission of COVID vaccine side-effects
The government said the ICMR had simply provided a list of advantages and disadvantages of COVID-19 vaccines through reputed websites of WHO, CDC and the ministry where compiled global evidence on various vaccines is available.
MC Exclusive | Bharat Biotech’s intranasal COVID-19 vaccine likely to be available only in corporate hospitals in major cities
Due to lack of rise in demand for booster doses, small private hospitals have showed no interest in procuring the vaccine despite the ease of administration it promises, say industry sources
Active Covid cases in country dip to 2,149
A decrease of 78 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
Nearly all of Beijing to get Covid by end of January, study finds
The virus has been spreading at a faster pace in China after the government relaxed controls in November and abruptly abandoned its Covid Zero policy in December, according to the study.
China reports almost 60,000 COVID-related deaths
The death toll included 5,503 deaths due to respiratory failure caused by COVID-19 and 54,435 fatalities from other ailments combined with COVID-19.
SII's free supply of Covishield to Centre: First lot of 80 lakh doses set for dispatch
Since the launch of the anti-Covid vaccination drive, SII has so far provided 170 crore doses of Covishield to the government.
COVID, Vaccine, SII, dispatch
Air travel recovers in China amid COVID infection worries
The rapid business recovery is challenging airlines’ ability to ensure safety, and great attention to pandemic-related risks is needed, said Song Zhiyong, head of the Civil Aviation Administration of China.
India logs 179 Covid cases in a day, active caseload declines by 30
A decrease of 30 cases has been recorded in the active COVID-19 caseload in 24 hours.
Piyush Goyal calls for redoubling efforts at WTO to get patent waiver for Covid diagnostics, therapeutics
In June last year, members of the WTO agreed to grant a temporary patent waiver for the manufacturing of COVID-19 vaccines for five years.
China Covid surge: Outbreak may continue for 2-3 months, warns Chinese scientist
Covid infections are expected to surge in rural areas as millions are set to travel to their home towns for the Lunar New Year holidays, which officially start from January 21.
As China reopens, online finger-pointing shows a widening gulf
A furious, wide-ranging argument is unfolding on the internet in China over the reversal of the government’s strict pandemic policies and the massive COVID surge that followed.
Acceptance of COVID-19 vaccines increased globally: Study
Of the 23,000 respondents surveyed, 1000 per country, 79.1 per cent were willing to accept vaccination. This finding represented an increase of 5.2 per cent from June 2021, the study said.
COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla
"Covovax will be approved as a booster in the next 10-15 days. It is actually the best booster because it works very well against Omicron, more than Covishield," said Poonawalla.
COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla
He said everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge and diverse population and also helped 70 to 80 nations during the COVID-19 pandemic.
Demand for Indian generic drugs skyrockets in China amid Covid surge
Due to the massive short supply of Paxlovid, demand for Indian generic versions has gone up through Chinese e-commerce platforms.
China's new Covid-19 control protocol calls for monitoring mutated variants: Report
China's national influenza surveillance network recommended that the results need to be reported to the Chinese Center for Disease Control and Prevention's Institute of Virology and among entry personnel at land, air, and virology to trace new mutant strains in a timely way.
Covishield immune responses against Covid variants higher than Covaxin: Study
Vaccination following exposure to the Delta or Omicron variants of SARS-CoV-2 is likely to affect the quality, quantity and duration of immune responses.
China’s COVID situation is dire – but it shouldn’t pose a big risk to other countries
Despite the popular perception that the current wave of infections is a direct result of the country lifting its zero COVID policy in early December, this isn’t quite true.
Covid news highlights: How COVID-19 can disturb your sleep and dreams and what could help
Covid news highlights: A review of all the currently available scientific literature, estimates that 52% of people who contract COVID suffer from sleep disturbances during the infection. The most common type of sleep disturbance reported is insomnia.
Germany to require rapid COVID-19 test for travellers from China
Germany is changing its entry rules for travellers from China and will in the future require at least a rapid coronavirus test to enter the country
China defends its COVID-19 response after WHO, Joe Biden express concern
The WHO's emergencies director, Mike Ryan, said on Wednesday in some of the U.N. health agency's most critical remarks to date, that Chinese officials were under-representing data on several fronts.
Four Omicron BF.7 cases detected in West Bengal
Genome sequencing of the four people, who have recently returned from the US, confirmed that they were infected with the new variant of the coronavirus
IATA terms COVID-19 restrictions on China a knee-jerk reinstatement of measures
Several countries are introducing COVID-19 testing and other measures for travellers from China, even though the virus is already circulating widely within their borders, according to IATA.
5 cases of Covid's XBB.1.5 variant found in India: INSACOG
Of the five, three cases were found in Gujarat and one each in Karnataka and Rajasthan, according to INSACOG figures on Tuesday.
